Effectiveness of ETI Combination Therapy for N1303K CFTR Variant
發布者：Unknown
·發布於：2025-12-13
Discussion regarding the effectiveness of Elexacaftor + Tezacaftor + Ivacaftor (ETI) combination therapy in restoring CFTR function specifically for Cystic Fibrosis patients with the N1303K variant.
載入中...